Peter Lebowitz
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Dr. Peter F.
Lebowitz is an Independent Director at Bridgebio Oncology Therapeutics, Inc., an Independent Director at Bridgebio Oncology Therapeutics, Inc. /New/, a Chief Executive & Medical Officer, Director at Third Arc Bio, Inc. and a Head-Oncology Therapeutic Area at Janssen Research & Development LLC.
He is on the Board of Directors at Bridgebio Oncology Therapeutics, Inc., Bridgebio Oncology Therapeutics, Inc. /New/ and Third Arc Bio, Inc. Dr. Lebowitz was previously employed as a Chief Executive Officer by Aragon Pharmaceuticals, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
-.--% | 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.